Sign In   Register

Cannabis and Hemp Industry Investment News

Cannabis Industry Press Releases and News Articles from the best investment journalist in the industry. Stay updated on all cannabis investment news from every online source, on MjInvest.com

Medlab Clinical in trading halt with placement announcement imminent

The company’s securities will remain halted until Tuesday, December 17 or when an announcement is released to the market. Medlab is developing therapi...

Medlab Clinical executes exclusive distribution agreement to expand into the UK

Medlab continues the offshore expansion of its nutraceuticals business with a UK partner following its US initiative announced in October. Medlab is d...

Medlab Clinical’s NanaBis observational study underway with positive early results

Over 100 Australian doctors and 200 patients have been enrolled in the observational study. Patients participating in the study have reported a reduct...

Medlab Clinical ahead of expectations with Phase 2 Depression Trial for NRGBiotic™

Study timelines are progressing as planned and at this point the trial should complete ahead of expectations. The company is seeking to expand commerc...

Medlab Clinical targets chronic diseases with nutraceutical-pharmaceutical pipeline

The company has two key divisions, pharmaceutical and nutraceutical. Medlab’s nutraceutical divisions allow for revenue generation, brand and company ...

Medlab Clinical converts HoA into commercial agreement for US expansion

First revenues from the commercial agreements are expected in early 2020. The US dietary supplements market was valued at US$124.8 billion in 2018 wit...

Medlab Clinical begins NanoCBD manufacturing after first export order for NanoCelle platform-based cannabinoid product

The company’s first NanoCBD sale offers validation of the product and differentiated delivery technology and points to the global prospects for Medlab...

Medlab Clinical obtains positive data proving efficacy of NanaBidial medicinal cannabis in completed phase-one trial

The clinical study was a blinded, randomised trial showing plasma concentrations were achieved quickly with a product half-life of about four hours. M...

Medlab Clinical continues US expansion with HoA

What are you searching for? viewMedlab Clinical Ltd Both companies are now working on both the definitive agreement and product market launch. The dea...

Medlab Clinical achieves over $3 million revenue for June quarter, shares rise

Medlab is a medical research company with a track record of bringing its nutraceutical and cannabis products to market. Medlab shares are trading up 1...

Medlab Clinical receives human ethics approval for cannabis-based pain management medicine trial

Medlab expects to roll this trial out to 2,000 patients across Australia, making it one of the most significant cannabis trials to date. NanaBis could...

Medlab Clinical signs second international distribution deal for NanaBis

The agreement is with a major international Thai pharmaceutical company. This follows a similar deal with Canada’s fourth largest generic pharmaceutic...

Medlab Clinical forges ahead in new vitamin trials for chronic illnesses

() chief executive officer Sean Hall tells Proactive Investors how the company is tapping into new areas of its “therapeutic toolkit” to better assist...

Medlab Clinical collaborates with Chronic Pain Australia

Medlab has two cannabis-based medicines, NanaBis™ and NanaBidial™. NanaBis™ is currently in clinical trial at Royal North Shore Hospital () has entere...

Medlab CEO presents clinical NanaBis update to medical practitioners

The company is pleased with data it has collected to date for NanaBis. Medlab also sees a regulatory pathway for NanaBis to become an approved drug ’s...

Medlab Clinical chief updates on progress with NanaBis and NRG Biotic

() managing director & CEO Sean Hall visits Proactive's Sydney studio following participation at the Australian Pharmacy Professional Conference &...

Medlab Clinical does deal for global distribution of NanaBis

The development and distribution deal is in the form of a heads of agreement. The HoA is with Canada’s fourth largest generic pharmaceutical company (...

Medlab Clinical expands depression trial recruitment, shares open 5% higher

New research corroborates the company’s direction of studying the use of NRGBiotic™ to improve gut health. Globally, more than 300 million people suff...

Medlab Clinical accelerating VMS business in Australia, and NanaBis globally

() managing director & CEO Sean Hall catches up with Proactive Investors about the biotech's progress so far in 2019. Hall teases, "We're planning...

Medlab Clinical signs deal to launch its nutraceuticals in Priceline Pharmacy

Along with Priceline, more than 2100 independent pharmacies will also be able to access Medlab’s nutraceutical range. The cannabis drug developer aims...


MjInvest.com